'Placebo patients' presentation slideshows

The Role of Pazopanib in the Treatment of Renal Cell Cancer

The Role of Pazopanib in the Treatment of Renal Cell Cancer. Robert Hawkins University of Manchester and The Christie Hospital, Manchester. Range of Drugs / Targets for RCC. Overview Pazopanib. Pazopanib is the most recently licensed drug for treatment of RCC

405 views • 40 slides

NHS Surrey Lipid Guidelines

567 views • 36 slides

491 views • 32 slides

Long -Term Efficacy of Dapagliflozin in T2DM Patients Receiving High-Dose Insulin

Long -Term Efficacy of Dapagliflozin in T2DM Patients Receiving High-Dose Insulin. John P.H. Wilding, DM, FRCP. Efficacy Outcome Measures. At week 24 Primary efficacy outcome Change in HbA1c Secondary efficacy outcomes Change in total body weight Change in mean daily insulin dose

285 views • 11 slides

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial. Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT. www.shift-study.com. Komajda M et al. Eur J Heart Fail. 2014;16(7):810-816.

218 views • 9 slides

Journal Insights Into: Oral Therapy for MS-Related Walking Impairment

Journal Insights Into: Oral Therapy for MS-Related Walking Impairment. Supplemental Slides. Dalfampridine Phase III Trials Responder Analysis. Responder analysis = % of patients in each group who respond, not mean differences between groups

149 views • 5 slides